NCT01135433View on ClinicalTrials.gov

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

May 15, 2010

Primary Completion Date

November 28, 2011

Study Completion Date

November 28, 2011

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

ipragliflozin

oral

DRUG

Placebo

oral

DRUG

metformin

oral

Trial Locations (7)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kantou

Kyushu

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY